KRAS and squamous cell carcinoma: Increased expression of KRAS protein was more frequent in squamous cell carcinomas and in lymph node metastasis compared to non-metastatic tumors (34 vs. 20 or 56.7 % vs. 33.3 %; P = 0.01).